• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pediatric Infect Dis Soc . Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case S

tetano

Editor, Senior Moderator
J Pediatric Infect Dis Soc


. 2021 Mar 13;piab011.
doi: 10.1093/jpids/piab011. Online ahead of print.
Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case Series From Mayotte Island


Chiara Cattaneo[SUP] 1 2 [/SUP], Maureen Drean[SUP] 1 [/SUP], Marion Subiros[SUP] 3 [/SUP], Patrice Combe[SUP] 1 [/SUP], Soumeth Abasse[SUP] 1 [/SUP], Abdourahim Chamouine[SUP] 1 [/SUP], Thomas Simon[SUP] 1 4 [/SUP]



Affiliations

Abstract

During the COVID-19 outbreak in the French overseas department Mayotte, 11 children developed multisystem inflammatory syndrome (MIS-C). They all had a fever and gastrointestinal symptoms. Six patients were admitted to intensive care unit; management included intravenous immunoglobulin and corticosteroid. Severe acute respiratory syndrome coronavirus 2 was documented in all patients. The risk of developing MIS-C was much higher than in all of France.

Keywords: Indian Ocean; MIS-C; Mayotte; SARS-CoV-2.
 
Back
Top Bottom